(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 330.45%30.89M | 70.53%35.4M | -93.93%70.76M | -98.80%12.66M | -45.56%30.17M | -75.44%7.18M | -27.84%20.76M | 1,363.26%1.17B | 102,841.78%1.05B | 150.85%55.42M |
Net interest income | -8.58%-2.55M | -7.87%-2.48M | 3.12%-9.48M | -5.77%-2.48M | 2.87%-2.37M | 7.97%-2.34M | 6.77%-2.3M | -10.04%-9.79M | 6.92%-2.34M | -14.21%-2.44M |
-Net interest income | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Total interest expense | 8.58%2.55M | 7.87%2.48M | -3.12%9.48M | 5.77%2.48M | -2.87%2.37M | -7.97%2.34M | -6.77%2.3M | 10.04%9.79M | -6.92%2.34M | 14.21%2.44M |
Non interest income | 251.19%33.43M | 64.28%37.89M | -93.17%80.24M | -98.57%15.13M | -43.77%32.53M | -70.03%9.52M | -26.17%23.06M | 1,227.30%1.18B | 29,719.15%1.05B | 138.82%57.86M |
-Dividend income | 3.30%23.43M | 22.54%24.03M | -92.40%85.11M | -97.98%21.5M | 7.73%21.33M | 18.72%22.68M | 2.42%19.61M | 852.69%1.12B | 5,713.20%1.06B | 13.42%19.8M |
Credit losses provision | ||||||||||
Non interest expense | ||||||||||
Selling and administrative expenses | 184.68%1.3M | 317.29%2.44M | 160.96%6.16M | 1,075.81%3.65M | 247.52%1.47M | -39.95%457K | -32.49%584K | -27.39%2.36M | -75.51%310K | -5.58%423K |
-General and administrative expense | 184.68%1.3M | 317.29%2.44M | 160.96%6.16M | 1,075.81%3.65M | 247.52%1.47M | -39.95%457K | -32.49%584K | -27.39%2.36M | -75.51%310K | -5.58%423K |
Income from associates and other participating interests | ||||||||||
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | 510.71%18.49M | 147.78%22.35M | -98.28%19.27M | -100.26%-2.72M | -59.86%17.47M | -126.31%-4.5M | -51.83%9.02M | 2,793.90%1.12B | 12,765.88%1.04B | 218.30%43.53M |
Income tax | -185.68%-3.12M | -321.59%-3.91M | 414.01%4.55M | -67.37%386K | 83.35%-1.25M | 193.61%3.65M | -79.82%1.77M | -120.10%-1.45M | 144.71%1.18M | -290.53%-7.48M |
Earnings from equity interest net of tax | ||||||||||
Net income | 365.29%21.61M | 261.98%26.26M | -98.69%14.72M | -100.30%-3.11M | -63.31%18.72M | -138.78%-8.15M | -27.31%7.25M | 3,460.82%1.12B | 18,761.51%1.04B | 423.36%51.01M |
Net Income continuous operations | 365.29%21.61M | 261.98%26.26M | -98.69%14.72M | -100.30%-3.11M | -63.31%18.72M | -138.78%-8.15M | -27.31%7.25M | 3,460.82%1.12B | 18,761.51%1.04B | 423.36%51.01M |
Noncontrolling interests | 0 | 0 | 1.28M | 1.28M | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to the company | 365.29%21.61M | 261.98%26.26M | -98.80%13.44M | -100.42%-4.39M | -63.31%18.72M | -138.78%-8.15M | -27.31%7.25M | 3,460.82%1.12B | 18,761.51%1.04B | 423.36%51.01M |
Preferred stock dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other under preferred stock dividend | 39.92%2.41M | -10.34%1.54M | 17.21%8.07M | 68.97%2.91M | -0.06%1.72M | -0.06%1.72M | 0.00%1.72M | -0.01%6.89M | -0.06%1.72M | 0.00%1.72M |
Net income attributable to common stockholders | 294.62%19.21M | 346.75%24.71M | -99.52%5.37M | -100.70%-7.29M | -65.52%17M | -151.17%-9.87M | -33.00%5.53M | 4,429.62%1.11B | 14,331.01%1.04B | 514.21%49.29M |
Diluted earnings per share | 280.00%0.27 | 337.50%0.35 | -99.52%0.08 | -65.33%0.26 | -151.72%-0.15 | -33.33%0.08 | 4,829.41%16.76 | 581.82%0.75 | ||
Basic earnings per share | 266.67%0.25 | 371.43%0.33 | -99.50%0.07 | -65.57%0.21 | -162.50%-0.15 | -30.00%0.07 | 4,857.14%13.88 | 577.78%0.61 | ||
Dividend per share | ||||||||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data